Effect of Hyperhomocysteinemia on Cardiac Function and Mortality of Patients with Acute Myocardial Infarction Concomitant Hypertension underwent Primary Percutaneous Coronary Intervention after 6 Months

Hai-ping ZHANG; Shu-juan YANG; Li-xia YANG; Zhao-juan RUAN; Rui-wei GUO

doi:10.12259/j.issn.2095-610X.S20210319

Volume 42 Issue 3

Apr. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2021 > 42(3): 73-78

Hai-ping ZHANG, Shu-juan YANG, Li-xia YANG, Zhao-juan RUAN, Rui-wei GUO. Effect of Hyperhomocysteinemia on Cardiac Function and Mortality of Patients with Acute Myocardial Infarction Concomitant Hypertension underwent Primary Percutaneous Coronary Intervention after 6 Months[J]. Journal of Kunming Medical University, 2021, 42(3): 73-78. doi: 10.12259/j.issn.2095-610X.S20210319

Citation:

Hai-ping ZHANG, Shu-juan YANG, Li-xia YANG, Zhao-juan RUAN, Rui-wei GUO. Effect of Hyperhomocysteinemia on Cardiac Function and Mortality of Patients with Acute Myocardial Infarction Concomitant Hypertension underwent Primary Percutaneous Coronary Intervention after 6 Months[J]. Journal of Kunming Medical University, 2021, 42(3): 73-78. doi: 10.12259/j.issn.2095-610X.S20210319

Citation:

Hai-ping ZHANG, Shu-juan YANG, Li-xia YANG, Zhao-juan RUAN, Rui-wei GUO. Effect of Hyperhomocysteinemia on Cardiac Function and Mortality of Patients with Acute Myocardial Infarction Concomitant Hypertension underwent Primary Percutaneous Coronary Intervention after 6 Months[J]. Journal of Kunming Medical University, 2021, 42(3): 73-78. doi: 10.12259/j.issn.2095-610X.S20210319

PDF( 615 KB)

Effect of Hyperhomocysteinemia on Cardiac Function and Mortality of Patients with Acute Myocardial Infarction Concomitant Hypertension underwent Primary Percutaneous Coronary Intervention after 6 Months

doi: 10.12259/j.issn.2095-610X.S20210319

1.
Dept. of Cardiology，Kunming Medical University，920th Hospital of Joint Logistics Support Force- teaching Hospital
2.
Dept. of Cardiology
3.
Dept. of Endocrinology，920th Hospital of Joint Logistics Support Force，Kunming Yunnan 650032，China

Received Date: 2020-12-06
Publish Date: 2021-04-09

Abstract

Abstract

Objective To identify the effect of hyperhomocysteinemia on cardiac function and mortality in patients with acute ST-segment elevation myocardial infarction concomitant hypertension underwent primary PCI after 6 months. Methods 192 patients in the Department of Cardiology, 920th Hospital of Joint Logistics Support Force with acute ST-segment elevation myocardial infarction concomitant hypertension who had undergone primary PCI was recruited from June 2015 to December 2016. 116 cases were excluded from the study owing to their incomplete follow-up data .The total remaining 78 patients were divided into two groups according to the level of homocysteine （Hcy） ≥15.0 mol/L: STEMI combined with H-type hypertension group （n = 39） and the STEMI combined with hypertension group （n = 38）. Baseline data of the two groups, relevant data during hospitalization and PCI, and left ventricular ejection fraction and cumulative mortality 6 months after surgery were compared. Results There were statistically significant differences in male proportion, serum creatinine and HCY between the two groups （P < 0.05）. There was statistically significant difference in the number of lesion vessels which was higher in the high Hcy group than in the control group （P < 0.012）. No statistically significant difference was showed in left ventricular ejection fraction at the time of hospitalization and the 6th month, the difference value between two left ventricular ejection fractions and the cumulative death at the 6th month between the two groups （all P > 0.05）. Conclusion Hyperhomocysteine has no effect on cardiac function and cumulative mortality 6 months after primary PCI in patients with acute ST-segment elevation myocardial infarction concomitant hypertension.
- Hyperhomocysteinemia,
- ST-segment elevated myocardial infarction,
- Hypertension,
- Percutaneous coronary intervention,
- Cardiac function,
- Mortality

FullText(HTML)

References(18)

References

[1]	Yeh J K,Chen C C,Hsieh M J,et al. Impact of homocysteine level on long-term cardiovascular outcomes in patients after coronary artery stenting[J]. Journal of Atherosclerosis and Thrombosis,2017,24(7):696-705. doi: 10.5551/jat.36434
[2]	Si J,Li X W,Wang Y,et al. Relationship between serum homocysteine levels and long-term outcomes in patients with ST-segment elevation myocardial infarction[J]. Chinese Medical Journal,2019,132(9):1028-1036. doi: 10.1097/CM9.0000000000000159
[3]	中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J]. 中华心血管病杂志,2019,47(10):766-783.
[4]	中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华高血压杂志,2011,19(8):701-743.
[5]	May H T,Alharethi R,Anderson J L,et al. Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery disease[J]. Cardiology,2007,107(3):178-184. doi: 10.1159/000095344
[6]	Cesari M,Zanchetta M,Burlina A,et al. Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives[J]. Arteriosclerosis,Thrombosis,and Vascular biology,2005,25(1):115-121. doi: 10.1161/01.ATV.0000149674.62430.e7
[7]	Joseph J,Washington A,Joseph L,et al. Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats[J]. Am J Physiol Heart Circ Physiol,2002,283(6):H2567-2574. doi: 10.1152/ajpheart.00475.2002
[8]	Graham I,Daly L,Refsum H,et al. Plasma homocysteine as a risk factor for vascular disease:The European concerted action project[J]. JAMA,1997,277(22):1775-1781. doi: 10.1001/jama.1997.03540460039030
[9]	Velagaleti R S,Gona P,Larson M G,et al. A Multimarker approach for the prediction of heart failure incidence in the community[J]. Circulation,2010,122(17):1700-1706. doi: 10.1161/CIRCULATIONAHA.109.929661
[10]	D’ ascenzo F,Iannaccone M,Saint-Hilary G,et al. Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events:a network meta-analysis of 64 randomized controlled trials and 102 735 patients[J]. European Heart Journal,2017,38(42):3160-3172. doi: 10.1093/eurheartj/ehx437
[11]	Palmerini T,Biondi-Zoccai G,Della Riva D,et al. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents:evidence from a comprehensive network meta-analysis[J]. Journal of the American College of Cardiology,2014,63(4):299-307. doi: 10.1016/j.jacc.2013.09.061
[12]	Wiviott S,Braunwald E,Mccabe C,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes[J]. N Engl J Med,2007,357(20):2001-2015. doi: 10.1056/NEJMoa0706482
[13]	Wallentin L,Becker R,Budaj A,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes[J]. N Engl J Med,2009,361(11):1045-1057. doi: 10.1056/NEJMoa0904327
[14]	Andell P,James S K,Cannon C P,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes and chronic obstructive pulmonary disease:An analysis from the platelet inhibition and patient outcomes (PLATO) Trial[J]. J Am Heart Assoc,2015,4(10):e002490.
[15]	Mahaffey K W,Wojdyla D M,Carroll K,et al. Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial[J]. Circulation,2011,124(5):544-554. doi: 10.1161/CIRCULATIONAHA.111.047498
[16]	刘师节,杨莉,何燕,等. 老年冠心病患者冠脉病变和血浆同型半胱氨酸水平的关系[J]. 昆明医科大学学报,2015,36(10):28-31. doi: 10.3969/j.issn.1003-4706.2015.10.007
[17]	Cohen E,Margalit I,Shochat T,et al. Gender differences in homocysteine concentrations,a population-based cross-sectional study[J]. Nutrition,Metabolism and Cardiovascular Diseases,2019,29(1):9-14.
[18]	周云枫,管又飞. 高同型半胱氨酸促进肾脏疾病的发生与发展[J]. 生理学报,2018,70(6):607-611.

Relative Articles(20)

Relative Articles

[1]	Jie FANG, Xuefeng GUANG, Xiaofeng LIN, Hailong DAI, Tongxi ZUO, Qi LAI. The Study on Application Timing of Intra-aortic Balloon Pump in ST-egment- elevation Myocardial Infarction Patients Complicated with Ventricular Septal Rupture. Journal of Kunming Medical University, 2025, 46(5): 1-5.
[2]	Da PENG, Aijun ZHANG. The Relationship between Urinary NGAL and Flow-mediated Vasodilation in Prehypertension. Journal of Kunming Medical University, 2024, 45(1): 127-132. doi: 10.12259/j.issn.2095-610X.S20240121
[3]	Linlin XUE, Binghan LI, Chunyun LIU, Weikun LI, Lixian CHANG, Huimin LI, Yanwei QI, Li LIU. Establishment and Evaluation of a Nomogram for Predicting Potential Death in Patients with Hepatitis C Cirrhosis and Sepsis in General Wards. Journal of Kunming Medical University, 2023, 44(6): 113-119. doi: 10.12259/j.issn.2095-610X.S20230630
[4]	Hualei DAI, Chengcheng HU, Guimin ZHANG, Siming TAO, Jiankun CHEN. Screening Biomarkers of Astragalus Membranaceus for Hypertensive Ventricular Remodeling Based on Network Pharmacology and Molecular Docking. Journal of Kunming Medical University, 2023, 44(8): 27-36. doi: 10.12259/j.issn.2095-610X.S20230819
[5]	Yan QIU, Yinli WANG, Mengmeng YANG, Liangmin GUO, Longhui YUAN. Association between MPV，PDW，PCT and Cardiac Function in Patients with Pulmonary Hypertension. Journal of Kunming Medical University, 2023, 44(12): 121-126. doi: 10.12259/j.issn.2095-610X.S20231219
[6]	Yao YANG, Jianxiong LIU, Yun ZHANG, Fanyi KONG, Shixiang LIU. Relationships between Large Artery Atherosclerotic Stroke and Cardiac Function. Journal of Kunming Medical University, 2022, 43(11): 107-111. doi: 10.12259/j.issn.2095-610X.S20221126
[7]	Wei-wen WANG, De-xia LI, Jie ZHANG, Lin LI. Correlation Between Serum Soluble ST2 and Cardiac Remodeling in Patients with Heart Failure with Reduced Ejection Fraction. Journal of Kunming Medical University, 2021, 42(8): 71-77. doi: 10.12259/j.issn.2095-610X.S20210813
[8]	Mei CEN, Dan-dan YUAN, Ming JIN, Xue-lian LIU, Wei-wei SHANG. Effect of Cardiac Exercise Rehabilitation on Cardiac Function and Quality of Life in Patients with Hypertensive Heart Disease Complicated with Heart Failure. Journal of Kunming Medical University, 2021, 42(5): 107-113. doi: 10.12259/j.issn.2095-610X.S20210520
[9]	Zhang Li Qiong , Cai Le , Zhang Hong Qing , Cui Wen Long , Liu Ying Nan , Shen Jing Rong , He Lian Ju . . Journal of Kunming Medical University, 2020, 41(03): 30-34.
[10]	Cong Lin Hai , Cao Guang Qiong , Li Cuan , Fang Hong Li , Gao Hui Fang , Deng Li. . Journal of Kunming Medical University, 2019, 40(10): 113-116.
[11]	Sun Cheng Huan , Zhou Jia , Mao Yong , Luo Jia Hong , Chu Tian Shu , Lai Chun Mi , Qi Bing Xian , Zhang Qing . The Awareness, Treatment and Control of Hypertension and Its Determinants in the Elderly Hypertensive Patients of Dean Nationality: A Multilevel Model Analysis. Journal of Kunming Medical University, 2018, 39(01): 39-44.
[12]	Fu Zhong Yang , Yi Jing . Clinical Observation of Treatment of Hypertension and Coronary Heart Disease with Amlodipine Atorvastatin Calcium Tablet. Journal of Kunming Medical University, 2017, 38(10): 117-119.
[13]	Wang Ya Nan , Li Zhi Gang , Zhang Chao , Li Shu De , Li Tao , Peng Jian Zhi . Homocysteine Suppress PI3K/Akt Signaling Pathway via Promoting the Expression of TRB3 in Adipose Tissue. Journal of Kunming Medical University, 2017, 38(06): 15-18.
[14]	Yuan Bin . Roles of Percutaneous Coronary Intervention in Improving Left Ventricular Function， Reducing Incidence of Cardiovascular Events of Patients With Ischemic Cardiomyopathy. Journal of Kunming Medical University,
[15]	Li Wen Hong . . Journal of Kunming Medical University,
[16]	Du Ying Rong . . Journal of Kunming Medical University,
[17]	Li Hong Fei . . Journal of Kunming Medical University,
[18]	Zhang Ti Ling . . Journal of Kunming Medical University,
[19]	Zhang Li Gang . . Journal of Kunming Medical University,
[20]	Pang Xing Mei . . Journal of Kunming Medical University,